After Glaxo's genital herpes vaccine flop, check out Agenus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : After Glaxo's genital herpes vaccine flop, check out Agenus

GSK 46.86

-0.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: albertaft	1/19/2015 9:33:33 AM
	Read Replies (1) of 22

GSK to receive 300 million for vaccine? Another article supporting $100+ a share for GSK in a couple weeks. <snip> "The talks also assessed the funding situation, after the GAVI global vaccines alliance said last month it was committing up to $300 million to buy Ebola shots." ebolatime.com Comment: Fasten your seat belts. GSK is about to explode.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next